Macrophage migration inhibitory factor (MIF): Mechanisms of action and role in disease

Microbes and Infection

Volumn 4, Issue 4, 2002, Pages 449-460

  Lue, Hongqi ^a   Kleemann, Robert ^b   Calandra, Thierry ^c   Roger, Thierry ^c   Bernhagen, Jürgen ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b TNO   (Netherlands)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cytokine; Inflammation; JAB1; MIF; Septic shock; Signaling

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR RECEPTOR; MEMBRANE RECEPTOR; PROTEIN; PROTEIN JAB1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CARCINOGENESIS; CELL PROLIFERATION; CHRONIC DISEASE; CORRELATION ANALYSIS; CORRELATION FUNCTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GLOMERULONEPHRITIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNITY; INFLAMMATION; MACROPHAGE MIGRATION; MOLECULAR BIOLOGY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; ARTERIOSCLEROSIS; ARTHRITIS, RHEUMATOID; DNA-BINDING PROTEINS; GLOMERULONEPHRITIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG DISEASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; NEOPLASMS; PEPTIDE HYDROLASES; RECEPTORS, IMMUNOLOGIC; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0036212743     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01560-5     Document Type: Review

References (101)

1. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
2. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction
3. Alterations of macrophage functions by mediators from lymphocytes
4. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
5. Molecular cloning of cDNA encoding a human macrophage migration inhibition factor
6. Regulation of the immune response by macrophage migration inhibitory factor: Biological and structural features
7. Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants
8. Cross-linking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF)
9. NMR characterization of structure, backbone dynamics and glutathione binding of the human macrophage migration inhibitory factor (MIF)
10. Macrophage migration inhibitory factor: A regulator of glucocorticoid activity with a critical role in inflammatory disease
11. Macrophage migration inhibitory factor (MIF) - A glucocorticoid counter-regulator within the immune system
12. Tumor growth-promoting properties of macrophage migration inhibitory factor
13. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor
14. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion
15. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
16. Regulation of the CTL response by macrophage migration inhibitory factor
17. MIF as a glucocorticoid-induced modulator of cytokine production
18. Macrophage migration inhibitory factor production by Leydig cells: Evidence for a role in the regulation of testicular function
19. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor
20. MIF expression in the rat brain - Implications for neuronal function
21. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome
22. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: Interaction with glucocorticoids
23. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα
24. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle
25. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria
26. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
27. Protection from septic shock by neutralization of macrophage migration inhibitory factor (MIF)
28. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice
29. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
30. Macrophage migration inhibitory factor in rheumatoid arthritis - Evidence of proinflammatory function and regulation by glucocorticoids
31. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
32. De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis
33. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis
34. Macrophage migration inhibitory factor expression in human renal allograft rejection
35. Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis
36. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma
37. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation
38. Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth
39. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma
40. A proinflammatory cytokine inhibits p53 tumor suppressor activity
41. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis
42. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung
43. Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells
44. Macrophage migration inhibitory factor in prostatic adenocarcinoma: Correlation with tumor grading and combination endocrine treatment-related changes
45. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis
46. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
47. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action
48. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis
49. A monoclonal antibody to human macrophage gangliosides inhibits macrophage migration
50. Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor
51. High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells
52. Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor
53. The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded β-sheets
54. A most interesting factor
55. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as a thiol-protein oxidoreductase
56. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction
57. Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines
58. Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: Potential role in cellular redox processes
59. Characterization of catalytic center mutants of macrophage migration inhibitory factor (MIF) and comparison with C81S MIF
60. Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor: Full immunologic activity of N-terminally truncated mutants
61. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor
62. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor
63. Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration
64. Regulation of macrophage migration inhibitory factor and thiol-specific antioxidant protein PAG by direct interaction
65. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor
66. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor
67. Arachidonic acid activates c-Jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells
68. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK
69. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)
70. Macrophage migration inhibitory factor induces killing of Leishmania major by macrophages: Dependence on reactive nitrogen intermediates and endogenous TNF-α
71. Protective effect on leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated salmonella typhimurium
72. Nitric oxide (NO) in apoptotic versus necrotic RAW 264.7 macrophage cell death: The role of NO-donor exposure, NAD+ content, and p53 accumulation
73. Antagonism of p53-dependent apoptosis by mitogen signals
74. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin
75. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation
76. Macrophage migration inhibitory factor-induced Ca(2+) response in rat testicular peritubular cells
77. Migration inhibitory factor expression in experimentally induced endotoxemia
78. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors
79. Characterization of the mouse JAB1 cDNA and protein
80. Kip1 is instigated by Jab1
81. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits
82. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to humans
83. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity
84. JAB1 interacts with both the progesterone receptor and SRC-1
85. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system
86. JAB1/CSN5 and the COP9 signalosome. A complex situation
87. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat
88. Macrophage migration inhibitory factor (MIF) and innate immune responses to bacterial infections
89. Cytokines as mediators in the pathogenesis of septic shock
90. Tumor necrosis factor: An updated view of its biology
91. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
92. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints
93. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability
94. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat
95. De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits
96. Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells
97. Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF